OmniActive Health Technologies

OmniActive Health Technologies is owned by Everstone Capital. Everstone Capital has a direct presence in 2 countries.

They are in:

• Fund50%
• Biotechnology50%

View the org chart displaying its 13 main executives

Most searched biographies at OmniActive Health Technologies

• Mark Dewis, Chief Executive Officer
• Sanjaya Mariwala, Chief Executive Officer and Executive Chairman o...
• Leendart Staal, Director

Create your alert
to follow the executive moves at OmniActive Health Technologies.

Everstone Capital has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by OmniActive Health Technologies

Social media about OmniActive Health Technologies

• OmniActive Health Technologies on Wikipedia, Google News & Yahoo Finance
• OmniActive Health Technologies on LinkedIn, Twitter & YouTube

Contact by email its executives including Mark Dewis

Call OmniActive Health Technologies at +91 222...

View the org chart

Register to receive your alert

Report an error